Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Latanoprostene Bunod bulk supplier for pharma manufacturers

Latanoprostene Bunod 0.024% Suppliers & Bulk Manufacturers

Available Forms: Eye Drops

Available Strengths: 0.024%

Reference Brands: Vyzulta (USA)

Category: Opthalmology

Latanoprostene Bunod is a Opthalmology product available as Eye Drops in strengths 0.024%. It corresponds to the reference brand Vyzulta (USA). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Latanoprostene bunod, marketed under the brand name Vyzulta, is an ophthalmic medication used to reduce elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. It is a prostaglandin F2α analog that undergoes enzymatic metabolism in the eye, producing latanoprost acid and nitric oxide, which work through complementary mechanisms to lower intraocular pressure.

Latanoprost acid increases aqueous humor outflow via the uveoscleral pathway, while nitric oxide relaxes the trabecular meshwork, enhancing conventional aqueous humor drainage. This dual action effectively reduces intraocular pressure, helping prevent optic nerve damage and vision loss associated with glaucoma.

Vyzulta is administered as an ophthalmic solution, typically once daily under the supervision of an ophthalmologist. Its targeted mechanism, combined with favorable safety and tolerability, makes it a valuable therapeutic option for patients requiring consistent intraocular pressure control. Latanoprostene bunod provides improved efficacy through dual outflow pathways, representing an advanced approach in the management of glaucoma and ocular hypertension.

Latanoprostene Bunod — third party manufacturing & bulk supply

Latanoprostene Bunod 0.024% is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Latanoprostene Bunod listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Latanoprostene Bunod →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Latanoprostene bunod is used to lower elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Latanoprostene bunod is a nitric oxide-donating prostaglandin analog formulated as an ophthalmic solution.

The trade name is Vyzulta.

Vyzulta is marketed by Bausch + Lomb.

The complete generic name is latanoprostene bunod.

The approved brand name is Vyzulta.

Latanoprostene bunod is manufactured in GMP-approved facilities in the USA and other regulated pharmaceutical regions.

Related Products

Artificial Tears

Strength:
0.3% to 1%

Form: Eye Drops/ Eye Gel/ Eye ointment

Reference Brands: Refresh Tears (USA/LATAM), Hylo-Tear (EU), Refresh Liquigel (India)

View Details
Tetrahydrozoline Hydrochloride

Strength:
0.05%

Form: Eye Drops

Reference Brands: Visine (USA/EU / LATAM), Ocuvis (India)

View Details
Faricimab

Strength:
6 mg/0.05 mL

Form: Injection

Reference Brands: Vabysmo (USA/EU)

View Details
Ranibizumab

Strength:
10 mg/mL

Form: Injection

Reference Brands: Lucentis (USA/EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.